Acute liver failure laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 38: Line 38:
|
|
* Total [[bilirubin]],  
* Total [[bilirubin]],  
|Elevated
|
* Elevated
|
|
* Bilirubin and PT/INR will will continue to rise in liver failure bua patienttient is improving, bilirubin and PT/INT will also improve.
* Bilirubin and PT/INR will will continue to rise in liver failure bua patienttient is improving, bilirubin and PT/INT will also improve.
Line 44: Line 45:
|
|
* Albumin
* Albumin
|Low
|
* Low
|
|
* Albumin indicates the synthetic function of the liver.
* Albumin indicates the synthetic function of the liver.
Line 78: Line 80:
*[[Viral hepatitis]] markers: anti-HAV IgM, HBSAg, anti-HBc IgM, anti-HEV
*[[Viral hepatitis]] markers: anti-HAV IgM, HBSAg, anti-HBc IgM, anti-HEV
|
|
* Dectectable in viral hepatitis.
* Dectectable in viral hepatitis
*
|
|
* Viral serology and PCR can detect the viral agent
* Viral serology and PCR can detect the viral agent

Revision as of 17:04, 16 November 2017

Acute liver failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Liver Failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute liver failure laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute liver failure laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute liver failure laboratory findings

CDC on Acute liver failure laboratory findings

Acute liver failure laboratory findings in the news

Blogs on Acute liver failure laboratory findings

Directions to Hospitals Treating Acute liver failure

Risk calculators and risk factors for Acute liver failure laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:


Overview

All patients with clinical or laboratory evidence of moderate to severe acute hepatitis should have an immediate measurement of prothrombin time and careful evaluation of mental status. If the prothrombin time is prolonged by ≈ 4-6 seconds or more (INR ≥1.5) and there is any evidence of altered sensorium, the diagnosis of ALF should be strongly suspected and hospital admission is mandatory.

Laboratory Findings

LAB values in Acute liver failure Comments
  • Increased
  • Prolonged prothrombin time, resulting in an INR ≥1.5; it shows coagulopathy which is a part of acute liver failure criteria.
  • Low
  • Anemia may be present
  • Elevated
  • Liver enzymes are elevated in acute liver failure. The decrease in liver enzymes may indicate recovery or worsening of liver failure and an indication of loss of hepatic mass.
  • Elevated
  • Bilirubin and PT/INR will will continue to rise in liver failure bua patienttient is improving, bilirubin and PT/INT will also improve.
  • Albumin
  • Low
  • Albumin indicates the synthetic function of the liver.
    • Blood glucose
  • Low
  • Decrease hepatic glycogenolysis and gluconeogenesis
  • BUN and CR
  • Elevated
  • Decrease clearance in hepatorenal syndrome
  • Toxicology screen (acetaminophen level)
  • Detectable in acetaminophen poisioning
  • Dectectable in viral hepatitis
  • Viral serology and PCR can detect the viral agent
  • Detectable in auto immune hepatitis.
  • Antibody screen can detect antibodies associated with autoimmune hepatitis such as anti-smooth muscle antibody or ANA.
  • Elevated in wilson's disease
  • Other metabolites (Potassium, phosphate )
  • Ammonia levels
  • Elevated
  • Decrease ammonia clearance

Initial laboratory examination must be extensive in order to evaluate both the etiology and severity.[1].


Initial laboratory analysis[1]

References

  1. 1.0 1.1 Polson J, Lee WM (2005). "AASLD position paper: the management of acute liver failure". Hepatology. 41 (5): 1179–97. doi:10.1002/hep.20703. PMID 15841455.

Template:WH Template:WS